Cargando…
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation
Gene therapy is a promising modality for the treatment of inherited and acquired cardiovascular diseases. The identification of the molecular pathways involved in the pathophysiology of heart failure and other associated cardiac diseases led to encouraging preclinical gene therapy studies in small a...
Autores principales: | Rincon, Melvin Y., VandenDriessche, Thierry, Chuah, Marinee K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571836/ https://www.ncbi.nlm.nih.gov/pubmed/26239654 http://dx.doi.org/10.1093/cvr/cvv205 |
Ejemplares similares
-
Preclinical and clinical advances in transposon-based gene therapy
por: Tipanee, Jaitip, et al.
Publicado: (2017) -
Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9
por: Singh, Kshitiz, et al.
Publicado: (2018) -
Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy
por: Tipanee, Jaitip, et al.
Publicado: (2022) -
Hyperactive PiggyBac Transposons for Sustained and Robust Liver-targeted Gene Therapy
por: Di Matteo, Mario, et al.
Publicado: (2014) -
Genome-wide Computational Analysis Reveals Cardiomyocyte-specific Transcriptional Cis-regulatory Motifs That Enable Efficient Cardiac Gene Therapy
por: Rincon, Melvin Y, et al.
Publicado: (2015)